Testing blood donors for HIV: current controversies

Area of Science:

• Transfusion Medicine
• Virology
• Public Health

Background:

• The risk of HIV transmission via screened blood transfusions is extremely low ( < 1 in 225,000 units).
• Despite low risk, there's pressure for additional donor screening and viral inactivation procedures.
• Decisions on new procedures require accurate residual risk estimates and projected risk reduction.

Purpose of the Study:

• To evaluate the necessity and impact of additional HIV screening and viral inactivation procedures in blood transfusions.
• To address the challenge of generating data for evaluating new measures as HIV risk declines.
• To refine understanding of early HIV seroconversion and donor characteristics within the window.

Main Methods:

• Analysis of residual HIV risk in blood donations.
• Focus on the infectious pre-seroconversion window.
• Evaluation of strategies to reduce donations during the window and inactivate the virus.

Main Results:

• Residual HIV risk is primarily from donations during the infectious pre-seroconversion window.
• Declining HIV risk presents challenges in generating data for new measure evaluation.
• Understanding early HIV virology and donor behavior is crucial.

Conclusions:

• Accurate HIV incidence data and understanding the seroconversion window are key to assuring blood supply safety.
• Rational policy decisions require data-driven evaluation of new procedures.
• Avoidance of unnecessary and non-specific procedures is recommended.